Preventative medicine and Alzheimer’s disease: is Alzheimer’s disease risk reduction achievable?
Open Access
- 1 January 2021
- journal article
- editorial
- Published by Medknow in Neural Regeneration Research
- Vol. 16 (9), 1772-1773
- https://doi.org/10.4103/1673-5374.306086
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Alternatives to amyloid for Alzheimer's disease therapies—a symposium reportAnnals of the New York Academy of Sciences, 2020
- Individualized clinical management of patients at risk for Alzheimer's dementiaAlzheimer's & Dementia, 2019
- Precision Medicine for Alzheimer’s Disease PreventionHealthcare, 2018
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- Do low‐serum vitamin E levels increase the risk of Alzheimer disease in older people? Evidence from a meta‐analysis of case‐control studiesInternational Journal of Geriatric Psychiatry, 2017
- A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trialThe Lancet, 2015
- MIND diet associated with reduced incidence of Alzheimer's diseaseAlzheimer's & Dementia, 2015
- Effect of Vitamin E and Memantine on Functional Decline in Alzheimer DiseaseJAMA, 2014
- Changes in Brain Function Occur Years before the Onset of Cognitive ImpairmentJournal of Neuroscience, 2013
- Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in VivoOnline Journal of Public Health Informatics, 2005